Login/Register
  • 中文
  • English

News

Senhwa Biosciences' twofold strategy post-pandemic aims at cancer and infection

Silmitasertib (CX-4945) will be used in the late stage development of the anti-infection field and Pidnarulex (CX-5461) has already started to be used in parallel with Pfizer's PARP inhibitor.

Read more
Dec 21, 2022
Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology
Oneness Biotech
Dec 21, 2022
Camcevi's U.S. Medicare coverage is more than three times higher than its peers
Economic Daily
Dec 21, 2022
Minimally invasive orthopaedic surgery has a promising future with strong support of Taiwanese industries
DIGITIMES
Dec 20, 2022
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
Press release
Dec 20, 2022
ASUS partners with GE to capture cloud-based AI medical imaging
Commercial Times
Dec 20, 2022
Taiwan-based biotech companies boost revenue through new trade orders and partnerships abroad
Commercial Times
Dec 19, 2022
Wong: the future of BIO+ICT has been clear
Commercial Times
Dec 19, 2022
Amendments to the telemedicine regulation to go into effect in January 2023
Economic Daily
Dec 19, 2022
Compal's business grows in healthcare
Economic Daily

Most Watched

Recommended

SurgiEyes – Surgical Robotic Real-time 3D Solution
AUO Display Plus
GXNPC1 (treating chronic stroke by using stem cell new drug)
Gwo Xi Stem Cell Applied Technology Co., Ltd.
iProtin Reader
tst biomedical electronics Co., Ltd.

Industry Watch

Read more